2007 Complication ER Utilities 
GeriPal
APRIL 10, 2025
You know, most, most ERs admit, you know, far fewer than 50% of their patients. They go to observation and go home or just get discharged straight from the ER? Yeah, that’s a more complicated story. But yeah, it’s complicated. Would it have changed potentially utilization rates like hospice utilization?
FDA Law Blog
SEPTEMBER 6, 2021
Teva submitted an ANDA in 2002, and after some complicated regulatory history, ultimately carved-out the congestive heart failure indication by way of a section viii statement. Teva received tentative approval in June 2003 and launched in 2007 after a blocking patent expired. Especially now with the utility of the use code minimized.
Expert insights. Personalized for you.
77 
Let's personalize your content